SRR’s new exciting pick for the week is ECTE. Echo Therapeutics has created a unique device  that may be used at home or in hospitals for diabetic patients to monitor their glucose levels. This non-invasive  monitoring system is created with no needles and is also wireless. Echo Therapeutics is in the development of acquiring the FDA regulations and is on it’s way to get passed by the FDA. Once Echo Therapeutics passes FDA approval we can assure you that ECTE will be on the NASDAQ  or AMEX exchange. ECTE is trading at $2.00 flat and will open tomorrow morning at that price. We suggest you take a closer look at ECTE and it’s potential before it jumps to the regulated market. http://www.echotx.com

FACTS

- They have a $15 million revenue agreement.

: $ 2 Net Change: 0.02 0.99% Share Volume: 316,641 Previous Close: $ 2.02 Today’s High: $ 2.15 Today’s Low: $ 1.90 Best Bid: N/A Best Ask: N/A 52 Week High: $ 2.04 52 Week Low: $ 0.251 P/E Ratio: NE Shares Outstanding: N/A Earnings Per Share (EPS): $ -0.76 Market Value: N/A

_

Share on Facebook